Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
- PMID: 33539753
- DOI: 10.1016/S1470-2045(20)30594-5
Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
Abstract
Female patients with childhood, adolescent, and young adult cancer are at increased risk for fertility impairment when treatment adversely affects the function of reproductive organs. Patients and their families desire biological children but substantial variations in clinical practice guidelines reduce consistent and timely implementation of effective interventions for fertility preservation across institutions. As part of the PanCareLIFE Consortium, and in collaboration with the International Late Effects of Childhood Cancer Guideline Harmonization Group, we reviewed the current literature and developed a clinical practice guideline for fertility preservation in female patients who were diagnosed with childhood, adolescent, and young adult cancer at age 25 years or younger, including guidance on risk assessment and available methods for fertility preservation. The Grading of Recommendations Assessment, Development and Evaluation methodology was used to grade the available evidence and to form the recommendations. This clinical practice guideline leverages existing evidence and international expertise to develop transparent recommendations that are easy to use to facilitate the care of female patients with childhood, adolescent, and young adult cancer who are at high risk for fertility impairment. A complete review of the existing evidence, including a quality assessment, transparent reporting of the guideline panel's decisions, and achievement of global interdisciplinary consensus, is an important result of this intensive collaboration.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Similar articles
-
Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group.Lancet Oncol. 2021 Feb;22(2):e57-e67. doi: 10.1016/S1470-2045(20)30582-9. Lancet Oncol. 2021. PMID: 33539754 Review.
-
Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group.Lancet Oncol. 2021 Feb;22(2):e68-e80. doi: 10.1016/S1470-2045(20)30595-7. Lancet Oncol. 2021. PMID: 33539755 Review.
-
[Current Status and Challenges in Oncofertility for Pediatric Cancer Patients].Gan To Kagaku Ryoho. 2023 Dec;50(12):1264-1268. Gan To Kagaku Ryoho. 2023. PMID: 38247061 Japanese.
-
Counseling and surveillance of obstetrical risks for female childhood, adolescent, and young adult cancer survivors: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Am J Obstet Gynecol. 2021 Jan;224(1):3-15. doi: 10.1016/j.ajog.2020.05.058. Epub 2020 Jun 2. Am J Obstet Gynecol. 2021. PMID: 32502557
-
Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium.Lancet Oncol. 2017 Feb;18(2):e75-e90. doi: 10.1016/S1470-2045(17)30026-8. Lancet Oncol. 2017. PMID: 28214419 Review.
Cited by
-
Current Status of Fertility Preservation in Pediatric Oncology Patients.Children (Basel). 2024 Apr 30;11(5):537. doi: 10.3390/children11050537. Children (Basel). 2024. PMID: 38790532 Free PMC article. Review.
-
Commentary on "Long-term endocrine sequelae after hematopoietic stem cell transplantation in children and adolescents".Ann Pediatr Endocrinol Metab. 2024 Apr;29(2):73-74. doi: 10.6065/apem.2423023edi02. Epub 2024 Apr 30. Ann Pediatr Endocrinol Metab. 2024. PMID: 38712490 Free PMC article. No abstract available.
-
IT-Related Barriers and Facilitators to the Implementation of a New European eHealth Solution, the Digital Survivorship Passport (SurPass Version 2.0): Semistructured Digital Survey.J Med Internet Res. 2024 May 2;26:e49910. doi: 10.2196/49910. J Med Internet Res. 2024. PMID: 38696248 Free PMC article.
-
The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults.Front Immunol. 2024 Apr 5;15:1378432. doi: 10.3389/fimmu.2024.1378432. eCollection 2024. Front Immunol. 2024. PMID: 38646536 Free PMC article. Review.
-
The oocyte microenvironment is altered in adolescents compared to oocyte donors.bioRxiv [Preprint]. 2024 Apr 6:2024.04.04.588118. doi: 10.1101/2024.04.04.588118. bioRxiv. 2024. PMID: 38617323 Free PMC article. Preprint.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials